bpc-157 benefits risks human studies BPC-157: Miracle Healing Peptide or Hidden Danger? BPC-157 Explained: Potential Benefits, Risks,

Oral BPC 157 has been studied in preclinical research with promising results

Commercial development was terminated in 2007

Equipment Researchers Typically Use Standard peptide reconstitution in a research setting relies on a small, consistent set of equipment: a sterile syringe appropriate to the vial size, an alcohol swab for disinfecting the vials rubber stopper before each entry, and a sealed bacteriostatic water vial

Absence of clinical safety data No Phase 1 clinical safety trial for BPC-157 has been completed and published

This study suggests that BPC-157 may represent a new peptide candidate for the treatment of periodontal disease